$RKDA
Arcadia Biosciences, Inc.

2017 Q3 Form 10-Q Financial Statement

#000156459017023329 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $589.0K $540.0K $102.0K
YoY Change 477.45% -60.0% -94.4%
Cost Of Revenue $40.00K $650.0K $60.00K
YoY Change -33.33% -2.99% -1.64%
Gross Profit $550.0K -$110.0K $42.00K
YoY Change 1209.52% -116.18% -97.62%
Gross Profit Margin 93.38% -20.37% 41.18%
Selling, General & Admin $2.415M $3.370M $2.687M
YoY Change -10.12% 17.01% -4.65%
% of Gross Profit 439.09% 6397.62%
Research & Development $1.749M $1.990M $2.255M
YoY Change -22.44% 6.42% -29.07%
% of Gross Profit 318.0% 5369.05%
Depreciation & Amortization $70.00K $70.00K $80.00K
YoY Change -12.5% -12.5% 14.29%
% of Gross Profit 12.73% 190.48%
Operating Expenses $4.204M $5.360M $5.002M
YoY Change -15.95% 12.84% -17.43%
Operating Profit -$3.615M -$5.470M -$3.927M
YoY Change -7.94% 34.4% -8.59%
Interest Expense $43.00K -$330.0K $331.0K
YoY Change -87.01% -49.23% -56.79%
% of Operating Profit
Other Income/Expense, Net $46.00K $100.0K $90.00K
YoY Change -48.89% -88.89% -68.42%
Pretax Income -$4.510M -$5.710M -$4.170M
YoY Change 8.15% 40.99% -11.58%
Income Tax $13.00K $0.00 $10.00K
% Of Pretax Income
Net Earnings -$4.525M -$5.710M -$4.180M
YoY Change 8.25% 47.93% -9.5%
Net Earnings / Revenue -768.25% -1057.41% -4098.04%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.127M -$2.572M -$1.883M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.70M $50.56M $53.89M
YoY Change -70.87% 0.64% -27.43%
Cash & Equivalents $2.930M $2.013M $10.47M
Short-Term Investments $12.77M $48.55M $43.41M
Other Short-Term Assets $1.100M $880.0K $1.190M
YoY Change -7.56% 27.54% 77.61%
Inventory $240.0K $250.0K $360.0K
Prepaid Expenses
Receivables $130.0K $530.0K $240.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.17M $52.22M $55.68M
YoY Change -69.16% 0.39% -27.35%
LONG-TERM ASSETS
Property, Plant & Equipment $370.0K $510.0K $580.0K
YoY Change -36.21% -12.82% -2.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $2.500M $3.480M
YoY Change -100.0% -87.34% 596.0%
Other Assets $1.440M $19.00K $1.850M
YoY Change -22.16% -24.0% 1713.73%
Total Long-Term Assets $1.810M $4.354M $5.910M
YoY Change -69.37% -80.41% 77.42%
TOTAL ASSETS
Total Short-Term Assets $17.17M $52.22M $55.68M
Total Long-Term Assets $1.810M $4.354M $5.910M
Total Assets $18.98M $56.57M $61.59M
YoY Change -69.18% -23.8% -22.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.00K $30.00K $20.00K
YoY Change 50.0% -93.18% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.520M $3.130M $3.830M
YoY Change -34.2% -9.28% -64.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $25.13M $25.08M
YoY Change -100.0% 0.79% 28.85%
Other Long-Term Liabilities $3.000M $3.000M $5.170M
YoY Change -41.97% 0.0% 72.33%
Total Long-Term Liabilities $3.000M $28.13M $25.08M
YoY Change -88.04% 0.71% 11.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.520M $3.130M $3.830M
Total Long-Term Liabilities $3.000M $28.13M $25.08M
Total Liabilities $8.311M $34.38M $34.08M
YoY Change -75.61% 1.06% -5.7%
SHAREHOLDERS EQUITY
Retained Earnings -$164.3M -$151.6M
YoY Change 14.88%
Common Stock $175.0M $173.8M
YoY Change 0.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.67M $22.20M $27.51M
YoY Change
Total Liabilities & Shareholders Equity $18.98M $56.57M $61.59M
YoY Change -69.19% -23.8% -22.99%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$4.525M -$5.710M -$4.180M
YoY Change 8.25% 47.93% -9.5%
Depreciation, Depletion And Amortization $70.00K $70.00K $80.00K
YoY Change -12.5% -12.5% 14.29%
Cash From Operating Activities -$2.360M -$4.280M -$3.930M
YoY Change -39.95% 8.35% -14.19%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$10.00K -$20.00K
YoY Change 0.0% -85.71% -66.67%
Acquisitions
YoY Change
Other Investing Activities $18.00M -$4.190M -$13.09M
YoY Change -237.51% -88.0% 15.94%
Cash From Investing Activities $17.97M -$4.200M -$13.11M
YoY Change -237.07% -88.0% 15.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.12M 20.00K 150.0K
YoY Change -17513.33% -133.33% -113.51%
NET CHANGE
Cash From Operating Activities -2.360M -4.280M -3.930M
Cash From Investing Activities 17.97M -4.200M -13.11M
Cash From Financing Activities -26.12M 20.00K 150.0K
Net Change In Cash -10.51M -8.460M -16.89M
YoY Change -37.77% -78.31% -0.88%
FREE CASH FLOW
Cash From Operating Activities -$2.360M -$4.280M -$3.930M
Capital Expenditures -$20.00K -$10.00K -$20.00K
Free Cash Flow -$2.340M -$4.270M -$3.910M
YoY Change -40.15% 10.05% -13.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25127000
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2791000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000000
CY2017Q3 us-gaap Liabilities
Liabilities
8311000
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
43000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
174925000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164297000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2520000
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
626000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56574000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3120000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
173723000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151550000
CY2016Q4 us-gaap Liabilities
Liabilities
34376000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
44000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
22198000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44487678
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44487678
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1749000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2415000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
42676916
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
90000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43272083
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44336324
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
10667000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4176000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
108000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
108000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12733000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
215000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
227000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
82000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-115000
us-gaap Share Based Compensation
ShareBasedCompensation
1177000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
98000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-276000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18978000
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2687000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
4204000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42683063
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42683063
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
82000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
102000
CY2017Q3 us-gaap Contracts Revenue
ContractsRevenue
363000
CY2016Q3 us-gaap Contracts Revenue
ContractsRevenue
755000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
589000
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-900000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-900000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
60000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2255000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
5002000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3615000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3927000
CY2017Q3 us-gaap Interest Expense
InterestExpense
43000
CY2016Q3 us-gaap Interest Expense
InterestExpense
331000
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44370061
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2000
us-gaap Share Based Compensation
ShareBasedCompensation
661000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
148000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-609000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-123000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
62000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-164000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
222000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
492000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
245000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
237000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-443000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-277000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11282000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12778000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2000
rkda Stock Option Exercise Cost Included In Accounts Receivable
StockOptionExerciseCostIncludedInAccountsReceivable
6000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-496000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
222000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19405000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
21129000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
57778000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
20247000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
38300000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1104000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
46000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1125000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
428000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-26101000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
382000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
917000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13500000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23973000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10473000
us-gaap Interest Paid
InterestPaid
746000
us-gaap Interest Paid
InterestPaid
755000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Arizona
rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2017Q3 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
45000
CY2016Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
44000
CY2017Q3 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1370000
CY2016Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1535000
CY2017Q3 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1415000
CY2016Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1579000
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
15402000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
15398000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
52613000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
52594000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
rkda Maturity Of Short Term Investments
MaturityOfShortTermInvestments
2017
rkda Number Of Long Term Investments Mature In Next Year
NumberOfLongTermInvestmentsMatureInNextYear
2
rkda Maturity Of Long Term Investments
MaturityOfLongTermInvestments
2018
CY2017Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
15398000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
52594000
us-gaap Variable Interest Entity Terms Of Arrangements
VariableInterestEntityTermsOfArrangements
Both the Company and Bioceres incur expenses in support of specific agreed activities, as defined by joint work plans, which apply fair market value to each partner’s activities. Unequal contributions of services are equalized by the partners through cash payments. Verdeca is not the primary obligor for these activities performed by the Company or Bioceres. An agreement executed in conjunction with the formation of Verdeca specified that if Bioceres determines it requires cash to fund its contributed services (subject to certain annual limits), Bioceres, S.A. may elect to sell shares of its common stock to the Company for an amount not exceeding $5.0 million in the aggregate over a four-year period.
rkda Contributed Services Period
ContributedServicesPeriod
P4Y
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
2000000
CY2014Q3 rkda Common Stock Shares Surrendered
CommonStockSharesSurrendered
1832
CY2015 rkda Research Agreement Settled
ResearchAgreementSettled
205000
CY2015Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
632
CY2015Q4 us-gaap Fair Value Hedges At Fair Value Net
FairValueHedgesAtFairValueNet
500000
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2017Q3 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
261000
CY2016Q3 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
487000
us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
98000
us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
221000
CY2016Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
25127000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
25127000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4578782
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2180217
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
893233
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5865766
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5804209
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2787853
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.38
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.42
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.15
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.16
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.91
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M
rkda Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P5Y
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7202660
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6029517

Files In Submission

Name View Source Status
0001564590-17-023329-index-headers.html Edgar Link pending
0001564590-17-023329-index.html Edgar Link pending
0001564590-17-023329.txt Edgar Link pending
0001564590-17-023329-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10q_20170930.htm Edgar Link pending
rkda-20170930.xml Edgar Link completed
rkda-20170930.xsd Edgar Link pending
rkda-20170930_cal.xml Edgar Link unprocessable
rkda-20170930_def.xml Edgar Link unprocessable
rkda-20170930_lab.xml Edgar Link unprocessable
rkda-20170930_pre.xml Edgar Link unprocessable
rkda-ex311_8.htm Edgar Link pending
rkda-ex312_7.htm Edgar Link pending
rkda-ex321_10.htm Edgar Link pending
rkda-ex322_6.htm Edgar Link pending
Show.js Edgar Link pending